Primary Care Clinics in Marfa, TX Accepting Medicare
3 Primary Care Clinics found. Showing 1 - 3
 Marfa Community Health Clinic Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 210 S Summer St, Marfa, TX 79843 Phone: 432-729-1800 Fax: 432-729-1806 |
Marfa Country Clinic, P.a. Clinic/Center - Primary Care Medicare: Medicare Enrolled Practice Location: 105 East Oak Street, Marfa, TX 79843 Phone: 432-729-3000 Fax: 432-729-3001 |
Marfa Rural Health Clinic Clinic/Center - Rural Health Medicare: Not Enrolled in Medicare Practice Location: 110 E Texas St, Marfa, TX 79843 Phone: 432-729-3310 |
News Archive
Children who received home visits from nurses are less likely to die from preventable causes
Low-income mothers and their first-born children who received home visits from nurses were less likely to die from preventable causes during a two-decade period studied by a University of Colorado School of Medicine professor, according to a report published in JAMA Pediatrics - a leading, peer-reviewed journal of the American Medical Association.
Journal explores polemic issues related to cosmetic surgery, body image and sexuality
Elsevier announced today the publication of the May 2010 issue of Reproductive Health Matters, which brings to light polemic issues related to cosmetic surgery, body image and sexuality. The issue explores the lack of proper information about the risks of complications and failure rate of many of these procedures.
Council discusses innovative model of care with Cleveland Clinic CEO
Today, the Nashville Health Care Council hosted 250 member executives for a conversation with Dr. Toby Cosgrove, president and CEO, Cleveland Clinic, about the Clinic's innovative model of care and focus on wellness of the mind and body.
Researchers use SNAP technology to assess fetal gene expression in amniotic fluid
Researchers have demonstrated the feasibility of focused fetal gene expression analysis of target genes found in amniotic fluid using Standardized NanoArray PCR (SNAP) technology.
Repros Therapeutics submits Androxal revised indication statement to the FDA
Repros Therapeutics Inc. today announced that the Company, as requested by the FDA during the Type C meeting held on January 25, 2010, has sent a revised indication statement to the FDA's Division of Reproductive and Urologic Products for the use of Androxal® in the treatment of men wishing to preserve fertility while being treated for their hypogonadal state.
› Verified 9 days ago